NO20054005L - Nye arylpiperazinylforbindelser - Google Patents
Nye arylpiperazinylforbindelserInfo
- Publication number
- NO20054005L NO20054005L NO20054005A NO20054005A NO20054005L NO 20054005 L NO20054005 L NO 20054005L NO 20054005 A NO20054005 A NO 20054005A NO 20054005 A NO20054005 A NO 20054005A NO 20054005 L NO20054005 L NO 20054005L
- Authority
- NO
- Norway
- Prior art keywords
- new
- arylpiperazinyl
- compounds
- adhd
- migraine
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 108091032151 5-hydroxytryptamine receptor family Proteins 0.000 abstract 2
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 2
- 102000040125 5-hydroxytryptamine receptor family Human genes 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 102000014630 G protein-coupled serotonin receptor activity proteins Human genes 0.000 abstract 1
- 208000011688 Generalised anxiety disease Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000029364 generalized anxiety disease Diseases 0.000 abstract 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 230000003961 neuronal insult Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000018 receptor agonist Substances 0.000 abstract 1
- 229940044601 receptor agonist Drugs 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- -1 sulfonamide compounds Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Gynecology & Obstetrics (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44398803P | 2003-01-31 | 2003-01-31 | |
| US45829703P | 2003-03-28 | 2003-03-28 | |
| US50352003P | 2003-09-16 | 2003-09-16 | |
| US10/768,579 US7153858B2 (en) | 2003-01-31 | 2004-01-30 | Arylpiperazinyl compounds |
| PCT/US2004/002858 WO2004069794A2 (fr) | 2003-01-31 | 2004-02-02 | Nouveaux composes d'arylpiperazinyle |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054005D0 NO20054005D0 (no) | 2005-08-29 |
| NO20054005L true NO20054005L (no) | 2005-10-27 |
Family
ID=32854494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054005A NO20054005L (no) | 2003-01-31 | 2005-08-29 | Nye arylpiperazinylforbindelser |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US7153858B2 (fr) |
| EP (1) | EP1592425A4 (fr) |
| JP (2) | JP4787148B2 (fr) |
| KR (1) | KR20060010717A (fr) |
| AU (1) | AU2004209020B2 (fr) |
| BR (1) | BRPI0407175A (fr) |
| CA (1) | CA2513915C (fr) |
| MA (1) | MA27715A1 (fr) |
| MX (1) | MXPA05008212A (fr) |
| NO (1) | NO20054005L (fr) |
| WO (1) | WO2004069794A2 (fr) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7153858B2 (en) * | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
| US20050222175A1 (en) * | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
| US7612078B2 (en) * | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
| AR047759A1 (es) | 2003-09-26 | 2006-02-22 | Vertex Pharma | Derivados de fenil - piperazina como moduladores de receptores muscarnicos |
| US7488736B2 (en) * | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| US7407966B2 (en) * | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| US7576211B2 (en) * | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
| US7598265B2 (en) * | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
| WO2006081332A1 (fr) | 2005-01-25 | 2006-08-03 | Epix Delaware, Inc. | Composes d'arylamine substitues et leur utilisation comme modulateurs de 5-ht6 |
| KR20080004533A (ko) * | 2005-03-29 | 2008-01-09 | 얀센 파마슈티카 엔.브이. | 피페라지닐 치환 사이클로헥산-1,4-디아민 |
| GB2454290B (en) | 2007-08-07 | 2009-09-30 | Prosarix Ltd | Novel serotonergic modulators |
| TW200914020A (en) * | 2007-08-28 | 2009-04-01 | Lilly Co Eli | Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists |
| AU2009244197A1 (en) * | 2008-05-08 | 2009-11-12 | Fabre Kramer Pharmaceuticals, Inc. | 3-hydroxy gepirone for the treatment of attention deficit disorder and sexual dysfunction |
| US20090281112A1 (en) * | 2008-05-08 | 2009-11-12 | Fabre-Kramer Pharmaceuticals, Inc. | Adatanserin and metabolites thereof for treatment of attention deficit disorder, anxiety, depression, sexual dysfunction, and other disorders |
| US8114894B2 (en) * | 2008-12-03 | 2012-02-14 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
| US8530479B2 (en) * | 2009-08-10 | 2013-09-10 | Daljit Singh Dhanoa | Deuterium-enriched alkyl sulfonamides |
| US8927553B2 (en) * | 2009-08-10 | 2015-01-06 | Daljit Singh Dhanoa | Deuterium-enriched alkyl sulfonamides and uses thereof |
| PL392436A1 (pl) | 2010-09-17 | 2012-03-26 | Adamed Spółka Z Ograniczoną Odpowiedzialnością | Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego |
| US9901827B2 (en) * | 2015-01-06 | 2018-02-27 | Spin Master Ltd. | Methods and system relating to physical constructions and virtual representations |
| CN117837837A (zh) | 2016-07-28 | 2024-04-09 | 莱施菲公司 | 施用一组睫毛嫁接物的方法、睫毛融合物及其制造方法 |
| CN120814720A (zh) | 2016-12-20 | 2025-10-21 | 拉什菲股份有限公司 | 人造睫毛延长部和施用器 |
| KR20210075903A (ko) | 2018-10-19 | 2021-06-23 | 래쉬파이 인코포레이티드 | 속눈썹 연장물을 적용하기 위한 어플리케이터 및 그의 사용 및 제조 방법 |
| USD863679S1 (en) | 2018-10-19 | 2019-10-15 | Lashify, Inc. | False eyelash applicator |
| JP1686171S (fr) | 2018-10-19 | 2021-05-24 | ||
| AU2020209745B2 (en) | 2019-01-14 | 2024-10-10 | Lashify, Inc. | Lash extensions and methods of manufacture and use thereof |
| CN211747241U (zh) | 2019-10-03 | 2020-10-27 | 莱施菲公司 | 人造睫毛装置及睫毛延长装置 |
| EP4159718A4 (fr) * | 2020-05-29 | 2023-10-04 | Daegu-Gyeongbuk Medical Innovation Foundation | Dérivé de sulfonamide et composition pharmaceutique le comprenant en tant que principe actif pour la prévention ou le traitement d'une maladie mentale |
| KR102447231B1 (ko) * | 2020-05-29 | 2022-09-27 | 재단법인 대구경북첨단의료산업진흥재단 | 설폰아미드 유도체 및 이를 유효성분으로 함유하는 정신질환의 예방 또는 치료용 약학적 조성물 |
| USD995914S1 (en) | 2022-07-20 | 2023-08-15 | Lashify, Inc. | Combined tweezer and applicator for artificial lash extensions |
| USD980521S1 (en) | 2022-07-20 | 2023-03-07 | Lashify, Inc. | Artificial lash extension separating comb |
| USD984050S1 (en) | 2022-07-20 | 2023-04-18 | Lashify, Inc. | Combined curler and applicator for natural lashes and artificial lash extensions |
| USD1072354S1 (en) | 2024-01-08 | 2025-04-22 | Lashify, Inc. | Rounded tweezer and applicator for artificial lash extensions |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2722529A (en) * | 1955-11-01 | Amides of certain l-amevoalkyl-x-phenyl | ||
| DK101683A (da) * | 1982-03-12 | 1983-09-13 | Duphar Int Res | Phenylpiperazinderivater og fremgangsmaade til fremstilling heraf |
| JPS5929665A (ja) * | 1982-08-11 | 1984-02-16 | Sumitomo Chem Co Ltd | ピペラジン誘導体及びその酸付加塩 |
| JP2556722B2 (ja) * | 1988-02-18 | 1996-11-20 | 興和株式会社 | 新規なスルホンアミド化合物 |
| DE3901814A1 (de) | 1988-07-28 | 1990-02-01 | Bayer Ag | Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga |
| US5300523A (en) | 1988-07-28 | 1994-04-05 | Bayer Aktiengesellschaft | Substituted aminomethyltetralins and their heterocyclic analogues |
| FR2655988B1 (fr) * | 1989-12-20 | 1994-05-20 | Adir Cie | Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| ZA929008B (en) | 1991-12-13 | 1993-05-21 | Bristol Myers Squibb Co | Piperazinyl- and piperidinyl-cyclohexanols. |
| IT1266582B1 (it) * | 1993-07-30 | 1997-01-09 | Recordati Chem Pharm | Derivati (di)azacicloesanici e diazacicloeptanici |
| JP3836892B2 (ja) * | 1993-12-27 | 2006-10-25 | トーアエイヨー株式会社 | 置換環状アミン化合物、その製造法及びそれを含有する循環器官用剤 |
| EP0661266A1 (fr) * | 1993-12-27 | 1995-07-05 | Toa Eiyo Ltd. | Composés cycliques aminés substitués comme 5HT2 antagonistes |
| FR2722788B1 (fr) | 1994-07-20 | 1996-10-04 | Pf Medicament | Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant |
| US5602124A (en) | 1994-12-12 | 1997-02-11 | Allelix Biopharmaceuticals, Inc. | 5-HT2 receptor ligands |
| JPH09202764A (ja) | 1996-01-24 | 1997-08-05 | Chugai Pharmaceut Co Ltd | ニトロ化合物 |
| DZ2376A1 (fr) | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
| CZ20004780A3 (cs) | 1998-06-19 | 2001-08-15 | H. Lundbeck A/S | Substituované 4-,5-,6-, nebo 7-indolové nebo indolinové deriváty |
| AR022303A1 (es) | 1999-01-22 | 2002-09-04 | Lundbeck & Co As H | Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion |
| GB9906624D0 (en) | 1999-03-23 | 1999-05-19 | Smithkline Beecham Plc | Novel compounds |
| US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
| US6645980B1 (en) | 2000-05-25 | 2003-11-11 | Sepracor Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US7361666B2 (en) | 1999-05-25 | 2008-04-22 | Sepracor, Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| US6635661B2 (en) | 2000-05-25 | 2003-10-21 | Sepracor Inc. | Heterocyclic analgesic compounds and methods of use thereof |
| AU2001238690A1 (en) | 2000-03-14 | 2001-09-24 | Sepracor, Inc. | 3-substituted piperidines comprising urea functionality, and methods of use thereof |
| AU9087301A (en) | 2000-09-11 | 2002-03-26 | Sepracor Inc | Ligands for monoamine receptors and transporters, and methods of use thereof |
| WO2002022579A2 (fr) | 2000-09-11 | 2002-03-21 | Sepracor, Inc. | Heterocycles sulfonamides antipsychotiques et leurs methodes d'utilisation |
| WO2002046157A2 (fr) | 2000-12-04 | 2002-06-13 | Sepracor, Inc. | Procedes de synthese stereoselective de piperidines substituees |
| WO2002069973A1 (fr) | 2001-03-02 | 2002-09-12 | Sepracor, Inc. | Ligand piperidine-piperazine pour recepteurs neurotransmetteurs |
| US7115607B2 (en) | 2001-07-25 | 2006-10-03 | Amgen Inc. | Substituted piperazinyl amides and methods of use |
| WO2003016274A2 (fr) | 2001-08-21 | 2003-02-27 | Sepracor, Inc. | Piperidines 2-substitue, ligands pour des recepteurs et des transporteurs de monoamines |
| JP4725945B2 (ja) * | 2002-03-13 | 2011-07-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒストンデアセチラーゼの新規な阻害剤としてのスルホニルアミノ誘導体 |
| US7153858B2 (en) | 2003-01-31 | 2006-12-26 | Epix Delaware, Inc. | Arylpiperazinyl compounds |
| WO2006081332A1 (fr) | 2005-01-25 | 2006-08-03 | Epix Delaware, Inc. | Composes d'arylamine substitues et leur utilisation comme modulateurs de 5-ht6 |
-
2004
- 2004-01-30 US US10/768,579 patent/US7153858B2/en not_active Expired - Fee Related
- 2004-02-02 JP JP2006503235A patent/JP4787148B2/ja not_active Expired - Fee Related
- 2004-02-02 MX MXPA05008212A patent/MXPA05008212A/es active IP Right Grant
- 2004-02-02 BR BR0407175-1A patent/BRPI0407175A/pt not_active IP Right Cessation
- 2004-02-02 WO PCT/US2004/002858 patent/WO2004069794A2/fr not_active Ceased
- 2004-02-02 EP EP04707409A patent/EP1592425A4/fr not_active Withdrawn
- 2004-02-02 AU AU2004209020A patent/AU2004209020B2/en not_active Expired - Fee Related
- 2004-02-02 KR KR1020057014179A patent/KR20060010717A/ko not_active Ceased
- 2004-02-02 CA CA2513915A patent/CA2513915C/fr not_active Expired - Fee Related
-
2005
- 2005-08-29 NO NO20054005A patent/NO20054005L/no not_active Application Discontinuation
- 2005-08-29 MA MA28470A patent/MA27715A1/fr unknown
-
2006
- 2006-09-05 US US11/516,345 patent/US7491727B2/en not_active Expired - Fee Related
-
2007
- 2007-07-24 US US11/782,415 patent/US7488731B2/en not_active Expired - Fee Related
-
2011
- 2011-06-06 JP JP2011126287A patent/JP2011207904A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004209020A1 (en) | 2004-08-19 |
| WO2004069794B1 (fr) | 2005-01-27 |
| US7153858B2 (en) | 2006-12-26 |
| US7491727B2 (en) | 2009-02-17 |
| MA27715A1 (fr) | 2006-01-02 |
| AU2004209020A2 (en) | 2004-08-19 |
| WO2004069794A2 (fr) | 2004-08-19 |
| MXPA05008212A (es) | 2006-01-17 |
| WO2004069794A9 (fr) | 2004-12-09 |
| BRPI0407175A (pt) | 2006-02-07 |
| EP1592425A4 (fr) | 2007-01-24 |
| JP4787148B2 (ja) | 2011-10-05 |
| AU2004209020B2 (en) | 2009-05-28 |
| JP2006516640A (ja) | 2006-07-06 |
| KR20060010717A (ko) | 2006-02-02 |
| CA2513915C (fr) | 2013-04-09 |
| US20080027066A1 (en) | 2008-01-31 |
| CA2513915A1 (fr) | 2004-08-19 |
| US20070004742A1 (en) | 2007-01-04 |
| US20040220192A1 (en) | 2004-11-04 |
| WO2004069794A3 (fr) | 2004-11-04 |
| NO20054005D0 (no) | 2005-08-29 |
| EP1592425A2 (fr) | 2005-11-09 |
| JP2011207904A (ja) | 2011-10-20 |
| US7488731B2 (en) | 2009-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054005L (no) | Nye arylpiperazinylforbindelser | |
| NO20055029D0 (no) | Nye piperidinylamino-tieno[2,3-di]pyrimidinforbindelser | |
| JP6337124B2 (ja) | インダゾール及びその使用 | |
| EA200600049A1 (ru) | Способы получения 3 - бензазепинов | |
| NO20052728L (no) | Substituerte tricykliske gamma-karboliner som serotonin reseptor agonister og antagonister | |
| NO20071660L (no) | Nye pyridinonderivater og deres anvendelse som positive allosteriske modulatorer av MGLUR2-reseptorer | |
| EA201000331A1 (ru) | 1',3-двузамещенные 4-(арил-х-фенил)-1h-пиридин-2-оны | |
| NO20045589L (no) | Nye forbindelser | |
| NO20072348L (no) | Thienopyridinone sammensetninger og fremgangsmate for behandling | |
| SE0302232D0 (sv) | Novel Compounds | |
| NO20080317L (no) | Substituerte tetrahydro-1H-Pyrido[4,3-B]Indoler som serotonin reseptor-agonister og antagonister | |
| TW200836743A (en) | Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions | |
| NO20064156L (no) | Indazolkarboksamidforbindelser som 5-HT4 receptoragonister | |
| EA201000314A1 (ru) | 1',3'-двузамещенные-4-фенил-3,4,5,6-тетрагидро-2h,1'h-[1,4']бипиридинил-2'-оны | |
| PT1716152E (pt) | Compostos heterocíclicos fundidos e sua utilização como antagonistas do receptor metabotrópico para o tratamento de distúrbios gastrointestinais | |
| NO20065814L (no) | Thiendopyridinon forbindelser og fremgangsmater for behandling | |
| JP2006524641A (ja) | 置換されたインドリンおよびインドール誘導体 | |
| PE20081496A1 (es) | Derivados de 2,5-dihidro-3-h-pirazolo[4,3-c]piridazin-3-ona sustituidos como antagonistas de los receptores cb1 | |
| EA201190004A1 (ru) | Конденсированные имидазол карбоксамиды в качестве модуляторов trpv3 | |
| NO20061909L (no) | 3-(4-aminofenyl)tienopyrimid-4-on derivater som MCH R-antagonister for behandling av fedme, diabetes,depresjon og angst | |
| EA200701588A1 (ru) | Способы получения замещённых фенилпиразолмочевин | |
| MX2015002398A (es) | Benzimidazoles como agentes activos del sistema nervioso central. | |
| NO20074884L (no) | Kinolinonforbindelser som 5-HT receptoragonister | |
| WO2012035123A1 (fr) | Arylsulfamides pour le traitement de maladies du snc | |
| BR0308070A (pt) | Agonistas do receptor beta3 adrenérgico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |